According to a recent LinkedIn post from Parallel Fluidics, the company recently concluded its presence at SLAS 2026, where it featured its LNP Screening Array. The post notes engagement with attendees interested in lipid nanoparticle screening workflows and indicates plans to follow up with visitors for demos and further discussions.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post also directs users who did not connect at the event to request a Starter Array for automating LNP screening on liquid-handling systems. For investors, this activity suggests ongoing commercial outreach in the lab automation and microfluidics space, potentially supporting lead generation, product validation, and future revenue opportunities in LNP-related research workflows.